U S PHYSICAL THERAPY INC /NV (USPH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 300M 600M 900M FY09: 201.4M FY10: 211.2M FY11: 231.5M FY12: 249.7M FY13: 264.1M FY14: 305.1M FY15: 331.3M FY16: 356.5M FY17: 414.1M FY18: 453.9M FY19: 482M FY20: 423M FY21: 495M FY22: 553.1M FY23: 604.8M FY24: 671.3M FY25: 781M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 60M 120M 180M FY10: 56M FY11: 55.9M FY12: 62.9M FY13: 64.7M FY14: 76.2M FY15: 78.4M FY16: 82M FY17: 90.6M FY18: 101.7M FY19: 112.5M FY20: 94.5M FY21: 117.2M FY22: 112M FY23: 121.5M FY24: 123.9M FY25: 149.7M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

0 30M 60M 90M FY09: 28.3M FY10: 33.2M FY11: 31.4M FY12: 38.4M FY13: 38.8M FY14: 45.8M FY15: 47.3M FY16: 49.5M FY17: 54.7M FY18: 60.3M FY19: 67.4M FY20: 52.4M FY21: 70.6M FY22: 56.8M FY23: 50.5M FY24: 63M FY25: 86.7M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

0 15M 30M 45M FY09: 11.8M FY10: 15.6M FY11: 21M FY12: 17.9M FY13: 12.7M FY14: 19.1M FY15: 20.6M FY16: 20.6M FY17: 22.3M FY18: 34.9M FY19: 40M FY20: 35.2M FY21: 40.8M FY22: 32.2M FY23: 28.2M FY24: 31.4M FY25: 39.6M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 250M 500M 750M FY09: 149.7M FY10: 155.2M FY11: 175.7M FY12: 186.7M FY13: 199.4M FY14: 228.9M FY15: 252.9M FY16: 274.5M FY17: 323.4M FY18: 352.2M FY19: 369.5M FY20: 328.5M FY21: 377.8M FY22: 441.1M FY23: 483.3M FY24: 547.4M FY25: 631.3M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

0 35M 70M 105M FY09: 30.9M FY10: 30.5M FY11: 32.7M FY12: 39.2M FY13: 44.8M FY14: 45.2M FY15: 37.5M FY16: 51M FY17: 56.5M FY18: 73M FY19: 62.4M FY20: 100M FY21: 76.4M FY22: 58.5M FY23: 82M FY24: 74.9M FY25: 75.1M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

0 35M 70M 105M FY09: 27.1M FY10: 26.8M FY11: 29.4M FY12: 35M FY13: 40.2M FY14: 40M FY15: 31.3M FY16: 42.8M FY17: 49.4M FY18: 65.8M FY19: 52.3M FY20: 92.4M FY21: 68.2M FY22: 50.3M FY23: 72.7M FY24: 65.8M FY25: 61M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 6M 12M 18M FY09: 11.8M FY10: 11.9M FY11: 12M FY12: 11.9M FY13: 12.1M FY14: 12.2M FY15: 12.4M FY16: 12.5M FY19: 12.8M FY20: 12.8M FY21: 12.9M FY22: 13M FY23: 14.2M FY24: 15.1M FY25: 15.2M FY09 FY11 FY13 FY15 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 1.50 3.00 4.50 Q4 '10: 1.32 Q1 '11: 1.37 Q2 '12: 1.82 Q3 '12: 1.86 Q4 '12: 1.50 Q1 '13: 1.43 Q2 '13: 1.43 Q3 '13: 1.07 Q4 '13: 1.06 Q1 '14: 1.02 Q2 '14: 1.13 Q3 '14: 1.54 Q4 '14: 1.63 Q1 '15: 1.70 Q2 '15: 1.66 Q3 '15: 1.70 Q4 '15: 1.77 Q1 '16: 1.86 Q2 '16: 1.95 Q3 '16: 1.94 Q4 '16: 1.88 Q1 '17: 1.83 Q2 '17: 1.65 Q3 '17: 1.60 Q4 '17: 1.75 Q1 '18: 1.64 Q2 '18: 1.73 Q3 '18: 1.45 Q4 '18: 1.31 Q1 '19: 1.43 Q2 '19: 1.80 Q3 '19: 2.33 Q4 '19: 2.45 Q1 '20: 2.26 Q2 '20: 2.40 Q3 '20: 2.35 Q4 '20: 2.48 Q1 '22: 2.87 Q2 '22: 2.92 Q3 '22: 2.98 Q4 '22: 2.24 Q1 '23: 2.15 Q2 '23: 1.92 Q3 '23: 1.71 Q4 '24: 1.84 Q1 '25: 2.18 Q2 '25: 2.29 Q3 '25: 2.38 Q1 '13 Q3 '14 Q1 '16 Q3 '17 Q1 '19 Q3 '20 Q1 '23 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.